{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 138,
  "pageCount": 239,
  "prevPage": 137,
  "nextPage": 139,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Uses direct quotes from KOLs to undermine the company's product launch narrative.",
  "elementsJson": [
    "headline_text",
    "subtitle_text",
    "bullet_list",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/138",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-138",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Omnia merely caters to Nevro users who turned away versus expanding the company's base",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b342-d26609a45397",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.8,
        "x": 0.06,
        "y": 0.22
      },
      "kind": "list",
      "text": "Omnia merely caters to Nevro users who turned away versus expanding the company’s base",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "07d951eb-9b5d-4388-8414-e9251e93f1b6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.88,
        "x": 0.06,
        "y": 0.46
      },
      "kind": "list",
      "text": "Omnia is an attempt to re-position the company after hitting the wall due to explants, but it’s “old stuff” as Nevro’s competitors have offered multiple wave form devices for most of this decade",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "543c7d98-bada-4105-aac3-bb615f71aaba",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.88,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "Although five pages of KOL commentary on Omnia may be overkill, the launch is key to the bull case and a broad sample of real-world doctor feedback may be useful to investors betting on Omnia as Nevro’s savior.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "96e713f3-c8d7-4365-a766-11f99a753d0e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.84,
        "x": 0.1,
        "y": 0.27
      },
      "kind": "quote",
      "text": "The Omnia works best for heavy Nevro users who stopped being users... The Nevro device is still big, just not as big as it was. They’re just going from zero share to 10% of my share.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d47e6069-f076-4d10-a29a-d3f65f9b3e0f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.84,
        "x": 0.1,
        "y": 0.53
      },
      "kind": "quote",
      "text": "Now all of a sudden Nevro realizes that with their explants rate, they’re going to have to do something new and sexy with Omnia [...] They’ve basically turned themselves into Boston Scientific... This is old stuff.",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e2c95469-5f74-449a-be7c-1fe40a150a25",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "\"The Omnia works best for heavy Nevro users who stopped being users. My share is 10% Nevro, 40% Boston, 25% Medtronic and 25% Abbot. Nevro's share will stay at 10%. I wasn't that happy with the anchor. If takes an extra half hour with the anchor it's a hassle. It's the biggest rechargeable there is. The only bigger stimulator is the Abbot non-rechargeable. The Nevro device is still big, just not as big as it was. They're just going from zero share to 10% of my share. These are chronic pain patients and if you give them something uncomfortable they'll complain about it a lot more. It's the population you're dealing with.\" — KOL, former heavy Nevro user who now uses it sparingly; \"Now all of a sudden Nevro realizes that with their explants rate, they're going to have to do something new and sexy with Omnia [...] They're basically turned themselves into Boston Scientific which has offered multiple waveforms ever since Spectrum launched in 2013. This is old stuff. They're saying 'I guess we better be competitive because our differentiation at 10khz failed.\" — KOL",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b342-d5cc51ddb932",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.06,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d856f817-4d05-4a1d-b2b6-45f9bdaf1f51",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.85,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e6337f76-dfec-436f-87cb-aafe662de02e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "98ce7b7a-f4ef-4e71-b7ac-286f5d3eae0c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "47f67e14-0c55-47c1-8f8c-118b7fd0cf09",
      "evidence": "Frames the company's product as a 'colossal flop' and 'old stuff' via expert testimony.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}